Author

Gomes Ribeiro Rafael da Cunha

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Reported effects of glucagon-like peptide-1 receptor agonists in multiple sclerosis: a scoping review of preclinical and clinical studies

Multiple sclerosis (MS) is a neuroinflammatory and neurodegenerative disease whose available therapies target peripheral immunity, leaving neurodegeneration unaddressed. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have shown neuroprotective and anti-inflammatory effects in preclinical models of neurodegenerat...

João Pedro Henriques, Maria J. S. Henriques, Gomes Ribeiro Rafael da Cunha et al. · The Egyptian Journal of Neur... · 0 citations

Review Open access Aug 2026

Therapeutic Impact of GLP‐1 Receptor Agonists on Parkinson's Disease: A Scoping Review

No disease‐modifying treatment exists for Parkinson's disease (PD). Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have gained attention as promising candidates for neuroprotection, given documented expression of GLP‐1 receptors within the central nervous system and the contribution of brain insulin resistan...

João Pedro Henriques, João Pedro Stringhetta Rahal, Gomes Ribeiro Rafael da Cunha et al. · Neurology and Clinical Neuro... · 0 citations